Melanoma During Pregnancy: Clinical Outcomes, Therapeutic Decision-Making, and Ethical–Medico-Legal Challenges—A Systematic Review
Onco · 30.10.2026 · 6 (4) · 52
DOI: 10.3390/onco6040052 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Onco, online erschienen am 30.10.2026. Verfasst von Helenia Mastrangelo und 7 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pregnancy-associated melanoma requires integration of maternal cancer prognosis with treatment, obstetric and fetal considerations.
Methods
PubMed/MEDLINE and OpenAlex searches were supplemented with Scopus and Web of Science Core Collection through 15 October 2026. The four export sets yielded 3460 records; conservative DOI/title deduplication retained 2642 unique records, after independent adjudication of 21 discordant-identifier groups. In accordance with the authors’ eligibility decisions, 16 publications (12 original and four newly identified observational studies) were retained for a narrative synthesis.
Results
Davidson et al. reported comparable five-year overall survival in 83 pregnancy-associated melanoma patients and 309 matched controls (97% versus 97%). Kostaki et al. described 70 pregnancy-associated melanomas within a 1270-woman European cohort, with a mean Breslow thickness of 1.16 mm and five-year recurrence-free survival of 95%. Grippaudo et al. reported multidisciplinary surgical management in 20 pregnant patients. Borgers et al. described 72 women with advanced melanoma across two partly overlapping pregnancy-related groups, illustrating high maternal and perinatal risks and variation in treatment timing.
Conclusions
Pregnancy itself is not consistently associated with adverse melanoma prognosis after accounting for disease characteristics, whereas treatment safety in gestation remains insufficiently established. Stage-specific, multidisciplinary and autonomy-respecting decisions are required; the evidence remains heterogeneous and registry populations must not be counted twice.
Zitieren
APA
Mastrangelo, H., Mastrangelo, I., Sacco, M. A., Gualtieri, S., Garofalo, E., Mazza, G., Neri, G., & Aquila, I. (2026). Melanoma During Pregnancy: Clinical Outcomes, Therapeutic Decision-Making, and Ethical–Medico-Legal Challenges—A Systematic Review. Onco, 6(4), 52. https://doi.org/10.3390/onco6040052
Vancouver
Mastrangelo H, Mastrangelo I, Sacco MA, Gualtieri S, Garofalo E, Mazza G, et al. Melanoma During Pregnancy: Clinical Outcomes, Therapeutic Decision-Making, and Ethical–Medico-Legal Challenges—A Systematic Review. Onco. 2026;6(4):52. doi:10.3390/onco6040052
BibTeX
@article{Mastrangelo2026,
author = {Mastrangelo, Helenia and Mastrangelo, Isadea and Sacco, Matteo Antonio and Gualtieri, Saverio and Garofalo, Eugenio and Mazza, Giuseppe and Neri, Giuseppe and Aquila, Isabella},
title = {Melanoma During Pregnancy: Clinical Outcomes, Therapeutic Decision-Making, and Ethical–Medico-Legal Challenges—A Systematic Review},
journal = {Onco},
year = {2026},
volume = {6},
number = {4},
pages = {52},
doi = {10.3390/onco6040052}
}
EUVIMED